Smile Care profit rises 21% to SAR 2.4M in H1 2024

Smile Care profit rises 21% to SAR 2.4M in H1 2024

26/12/2024 Argaam Exclusive

View other reports

Basma Adeem Medical Co. (Smile Care), set to list on the Nomu-Parallel Market, reported an increase in profits to SAR 2.4 million for the first half of 2024, compared to SAR 2 million a year ago.



Financials (M)

Item 6m 2023 6m 2024 Change‬
Revenues 11.73 15.41 31.4 %
Gross Income 3.48 4.61 32.5 %
Operating Income 2.24 2.64 17.8 %
Net Income 1.98 2.38 20.6 %
Average Shares 8.26 16.00 93.8 %
Earnings Per Share before unusual items 0.24 0.15 (37.8 %)
EPS (Riyals) 0.24 0.15 (37.8 %)

The six-month profit growth was attributed to a 31.4% rise in revenues to SAR 15.4 million in H1 2024, compared to SAR 11.7 million in H1 2023.

 

This contributed to an increase in the gross profit margin for the current period to 29.9%, compared to 29.7% for the same period last year. Additionally, the cost-to-revenue ratio declined to 70.1% in H1 2024.



Current Half Annual Comparison (M)

Compared With The
Item H1 2023 H1 2024 Change‬
Revenues 11.73 15.41 31.4 %
Gross Income 3.48 4.61 32.5 %
Operating Income 2.24 2.64 17.8 %
Net Income 1.98 2.38 20.6 %
Average Shares 8.26 16.00 93.8 %
Earnings Per Share before unusual items 0.24 0.15 (37.8 %)
EPS (Riyals) 0.24 0.15 (37.8 %)

On a biannual basis, net income declined 17.6% from SAR 2.89 million in H2 2023.

 

Total shareholders’ equity stood at SAR 18.7 million as of the end of H1 2024, compared to SAR 6.9 million in the prior-year period.



Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 - - - - - -
H2 2020 - - - - - -
H1 2021 - - - - - -
H2 2021 - - - - - -
H1 2022 - - - - - -
H2 2022 - - - - - -
H1 2023 11.73 - 3.48 - 2.24 -
H2 2023 14.79 - 4.86 - 3.00 -
H1 2024 15.41 31.4 % 4.61 32.5 % 2.64 17.8 %


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items Earnings Per Share before unusual items
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 - - - - - -
H2 2020 - - - - - -
H1 2021 - - - - - -
H2 2021 - - - - - -
H1 2022 - - - - - -
H2 2022 - - - - - -
H1 2023 1.98 - 0.24 - 1.98 0.24
H2 2023 2.89 - 0.35 - 2.89 0.35
H1 2024 2.38 20.6 % 0.15 - 2.38 0.15

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 - - -
H2 2022 - - -
H1 2023 - - -
H2 2023 - - -
H1 2024 - - -


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Earnings Per Share before unusual items (Riyal) Book Value (BV)
H1 2015 - - - -
H2 2015 - - - -
H1 2016 - - - -
H2 2016 - - - -
H1 2017 - - - -
H2 2017 - - - -
H1 2018 - - - -
H2 2018 - - - -
H1 2019 - - - -
H2 2019 - - - -
H1 2020 - - - -
H2 2020 - - - -
H1 2021 - - - -
H2 2021 - - - -
H1 2022 - - - -
H2 2022 - - - -
H1 2023 8.26 - - 0.84
H2 2023 8.26 - - 1.19
H1 2024 16.00 - - 1.17

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 - - -
H2 2022 - - -
H1 2023 - - -
H2 2023 - - -
H1 2024 - - -


Share Price

Basma Adeem Medical Co.
5.72
1.32 30.00 %

Basma Adeem Medical Co. (SMILE CARE)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.